FindTrial
Sign In

nausea and vomiting therapy

PROCEDURE5 trials

Sponsors

NCIC Clinical Trials Group, M.D. Anderson Cancer Center, University of Washington, Cambridge University Hospitals NHS Foundation Trust, Wake Forest University Health Sciences

Conditions

Adenocarcinoma of the Gastroesophageal JunctionBreast CancerDrug-induced Nausea and VomitingEsophageal CancerExtrahepatic Bile Duct CancerFatigueGastric CancerLung Cancer

Phase 2

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer
CompletedNCT01534637
Wake Forest University Health SciencesExtrahepatic Bile Duct Cancer, Nausea, Stage III Pancreatic Cancer +3
Start: 2006-08-31End: 2012-08-31Updated: 2018-08-15

Phase 3

Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
CompletedNCT00046865
M.D. Anderson Cancer CenterBreast Cancer, Drug-induced Nausea and Vomiting
Start: 2002-07-01End: 2006-03-23Updated: 2018-11-14
Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer
CompletedNCT00003685
NCIC Clinical Trials GroupFatigue, Lung Cancer, Nausea and Vomiting +3
Start: 1997-08-01End: 2009-02-10Updated: 2020-04-03
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer
CompletedNCT00978549
Cambridge University Hospitals NHS Foundation TrustAdenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer +2
Start: 2008-04-30End: 2010-10-31Target: 320Updated: 2013-08-07

Unknown Phase

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
CompletedNCT00343863
University of WashingtonMale Breast Cancer, Nausea and Vomiting, Stage I Breast Cancer +2
Start: 2006-01-31End: 2010-12-31Updated: 2017-07-11